Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation von von Bahr, L., Batsis, I., Moll, G., Hägg, M., Szakos, A., Sundberg, B., Uzunel, M., Ringden, O., Le Blanc, K.

Volltext

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation von Mougiakakos, D, Jitschin, R, von Bahr, L, Poschke, I, Gary, R, Sundberg, B, Gerbitz, A, Ljungman, P, Le Blanc, K

Volltext

Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation von von Bahr, L, Blennow, O, Alm, J, Björklund, A, Malmberg, K-J, Mougiakakos, D, Le Blanc, A, Oefner, P J, Labopin, M, Ljungman, P, Le Blanc, K

Volltext

Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties? von Moll, Guido, Alm, Jessica J., Davies, Lindsay C., von Bahr, Lena, Heldring, Nina, Stenbeck‐Funke, Lillemor, Hamad, Osama A., Hinsch, Robin, Ignatowicz, Lech, Locke, Matthew, Lönnies, Helena, Lambris, John D., Teramura, Yuji, Nilsson‐Ekdahl, Kristina, Nilsson, Bo, Blanc, Katarina

Volltext

Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood? von Moll, Guido, Rasmusson-Duprez, Ida, von Bahr, Lena, Connolly-Andersen, Anne-Marie, Elgue, Graciela, Funke, Lillemor, Hamad, Osama A., Lönnies, Helena, Magnusson, Peetra U., Sanchez, Javier, Teramura, Yuji, Nilsson-Ekdahl, Kristina, Ringdén, Olle, Korsgren, Olle, Nilsson, Bo, Le Blanc, Katarina

Volltext

Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells? von Moll, Guido, Hult, Annika, von Bahr, Lena, Alm, Jessica J, Heldring, Nina, Hamad, Osama A, Stenbeck-Funke, Lillemor, Larsson, Stella, Teramura, Yuji, Roelofs, Helene, Nilsson, Bo, Fibbe, Willem E, Olsson, Martin L, Le Blanc, Katarina

Volltext

Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses von Moll, Guido, Jitschin, Regina, von Bahr, Lena, Rasmusson-Duprez, Ida, Sundberg, Berit, Lönnies, Lena, Elgue, Graciela, Nilsson-Ekdahl, Kristina, Mougiakakos, Dimitrios, Lambris, John D, Ringdén, Olle, Le Blanc, Katarina, Nilsson, Bo

Volltext

Alterations in the Cellular Immune Compartment of Patients Treated with Third‐Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation von Jitschin, Regina, Mougiakakos, Dimitrios, Von Bahr, Lena, Völkl, Simon, Moll, Guido, Ringden, Olle, Kiessling, Rolf, Linder, Stig, Le Blanc, Katarina

Volltext

Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease-a gut feeling von Gavin, Caroline, Boberg, Erik, Von Bahr, Lena, Bottai, Matteo, Andrén, Anton Törnqvist, Wernerson, Annika, Davies, Lindsay C, Sugars, Rachael V, Le Blanc, Katarina

Volltext

Enhanced oral healing following local mesenchymal stromal cell therapy von Garming-Legert, Karin, Tour, Gregory, Sugars, Rachael, von Bahr, Lena, Davies, Lindsay C, Le Blanc, Katarina

Volltext

Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy von von Bahr, Lena, Sundberg, Berit, Lönnies, Lena, Sander, Birgitta, Karbach, Holger, Hägglund, Hans, Ljungman, Per, Gustafsson, Britt, Karlsson, Helen, Le Blanc, Katarina, Ringdén, Olle

Volltext

Treatment of chronicGvHDwith mesenchymal stromal cells induces durable responses: A phaseIIstudy von Boberg, Erik, von Bahr, Lena, Afram, Gabriel, Lindstrom, Carina, Ljungman, Per, Heldring, Nina, Petzelbauer, Peter, Legert, Karin Garming, Kadri, Nadir, Le Blanc, Katarina

Volltext

Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study von Boberg, Erik, Bahr, Lena, Afram, Gabriel, Lindström, Carina, Ljungman, Per, Heldring, Nina, Petzelbauer, Peter, Garming Legert, Karin, Kadri, Nadir, Le Blanc, Katarina

Volltext

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation von Mougiakakos, D, Jitschin, R, von Bahr, L, Poschke, I, Gary, R, Sundberg, B, Gerbitz, A, Ljungman, P, Le Blanc, K

Volltext

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROW AND PERIPHERAL BLOOD AFTER ALL... von Lindholm, C., Tobiasson, M., Pandzic, T., Illman, J., Nilsson, L., Weström, S., Ejerblad, E., Olesen, G., Björklund, A., Kittang, A. Olsnes, Werlenius, O., Wiggh, J., Lorentz, F., Rasmussen, B., Cammenga, J., Weber, D., Moen, A.E., Lundström, L.Y., Bahr, L. Von, Dimitriou, M., Kytölä, S., Walldin, G., Ljungman, P., Groenbaek, K., Mielke, S., Jacobsen, S.E., Ebeling, F., Cavelier, L., Friis, L. Smidstrup, Dybedal, I., Hellstrom-Lindberg, E.

Volltext

Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study von Von Bahr, Lena, Davies, Lindsay, Afram, Gabriel, Modin, Carina, Garming-Legert, Karin, Hägglund, Hans, Ljungman, Per T., Le Blanc, Katarina

Volltext

COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROWAND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS von Lindholm, C, Tobiasson, M, Pandzic, T, Illman, J, Nilsson, L, Westrom, S, Ejerblad, E, Olesen, G, Bjorklund, A, Kittang, AO, Werlenius, O, Wiggh, J, Lorentz, F, Rasmussen, B, Cammenga, J, Weber, D, Moen, AE, Lundstrom, LY, Von Bahr, L, Dimitriou, M, Kytola, S, Walldin, G, Ljungman, P, Groenbaek, K, Mielke, S, Jacobsen, SE, Ebeling, F, Cavelier, L, Friis, LS, Dybedal, I, Hellstrom-Lindberg, E

Volltext

Immunosuppressive CD14 super(+)HLA-DR super(low/neg) IDO super(+) myeloid cells in patients following allogeneic hematopoietic stem cell transplantation von Mougiakakos, D, Jitschin, R, von Bahr, L, Poschke, I, Gary, R, Sundberg, B, Gerbitz, A, Ljungman, P, Le Blanc, K

Volltext

Immunosuppressive [CD14.sup.+] [HLA-DR.sup.low/neg] [IDO.sup.+] myeloid cells in patients following allogeneic hematopoietic stem cell transplantation von Mougiakakos, D, Jitschin, R, von Bahr, L, Poschke, I, Gary, R, Sundberg, B, Gerbitz, A, Ljungman, P, Le Blanc, K

Volltext

Immunosuppressive CD14 + HLA-DR low/neg IDO + myeloid cells in patients following allogeneic hematopoietic stem cell transplantation von Mougiakakos, D, Jitschin, R, von, Bahr L, Poschke, I, Gary, R, Sundberg, B, Gerbitz, A, Ljungman, P, Le, Blanc K

Volltext